Off-label or out of bounds? Prescriber and marketer liability for unapproved uses of FDA-approved drugs.
Authors:
- James O'ReillyJOJames O'Reilly
- Amy DalalADAmy Dalal
- 1 January 2003
- journal article
- other
- Vol. 12 (2) , 295